Tianjiao Ji
| Title： |
Professor |
| E-mail： |
jitj(AT)nanoctr.cn |
| Affiliation： |
National Center for Nanoscience and Technology (NCNST）
No.11 Beiyitiao Zhongguancun,
100190 Beijing,
P. R. China |
| Group Webpage： |
|
Education and Professional Experience:
1. September 2020- Professor, Principal Investigator CAS Key Laboratory for Biomedical Effects of Nanomaterials & Nanosafety, National Center for Nanoscience and Technology
2. August 2016-2020 Research Fellow (Postdoc) Laboratory for Biomaterials and Drug Delivery, Department of Anesthesiology, Boston Children’s Hospital, Harvard Medical School, Principal Investigator: Prof. Daniel S. Kohane
3. August 2016-2020 Research Affiliate David H. Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Principal Investigator: Prof. Robert Langer
4. Sept 2011-July 2016 Ph.D. National Center for Nanoscience and Technology, Major: Physical Chemistry; Supervisor: Prof. Guangjun Nie
5. Sept 2007- July 2011 B.S. Wuhan University, Major: Chemistry; Supervisor: Prof. Xian-zheng Zhang
1. Z. Lian, T. Ji*. Functional Peptide-Based Drug Delivery Systems. J. Mater. Chem. B 2020, 8, 6517-6529. (“Emerging Investigators 2020” invited).
2. T. Ji, J. Lang, B. Ning, F. Qi, H. Wang, Y. Zhang, R. Zhao, X. Yang, L. Zhang, W. Li, X. Shi, Z. Qin, Y. Zhao, G. Nie. Enhanced Natural Killer Cell Immunotherapy by Rationally Assembling Fc Fragments of Antibodies onto Tumor Membranes. Adv. Mater. 2019, 31, 1804395.
3. T. Ji, D. S. Kohane*. Nanoscale systems for local drug delivery. Nano Today 2019, 28, 10765.
4. J. Lang, X. Zhao, Y. Qi, Y. Zhang, X. Han, Y. Ding, J. Guan, T. Ji*, Y. Zhao*, G. Nie*. Reshaping Prostate Tumor Microenvironment to Suppress Metastasis via Cancer-Associated Fibroblast Inactivation with Peptide-Assembly-Based Nanosystem. ACS Nano 2019, 13, 12357-12371.
5. C. Weldon, T. Ji (co-first author), M. T. Nguyen (co-first author), A. Rwei, W. Wang, Y. Hao, C. Zhao, M. Mehta, B. Y. Wang, J. Tsui, R. P. Marini, D. S. Kohane*. Nanoscale Bupivacaine Formulations to Enhance the Duration and Safety of Intravenous Regional Anesthesia. ACS Nano 2019, 13, 18-25.
6. T. Ji, J. Lang, J. Wang, R. Cai, Y. Zhang, F. Qi, L. Zhang, X. Zhao, W. Wu, J. Hao, Z. Qin, Y. Zhao, G. Nie*. Designing Liposomes to Suppress Extracellular Matrix Expression to Enhance Drug Penetration and Pancreatic Tumor Therapy. ACS Nano 2017, 11, 8668-8678.
7. T. Ji, Y. Zhao, Y. Ding, J. Wang, R. Zhao, J. Lang, H. Qin, X. Liu, J. Shi, N. Tao, Z. Qin, G. Nie, YL. Zhao*. Transformable Peptide Nanocarriers for Expeditious Drug Release and Effective Cancer Therapy via Cancer-associated Fibroblasts Activation. Angew. Chem. Int. Ed. 2016, 55, 1050-1055.
8. T. Ji, Y. Ding, Y. Zhao, J. Wang, H. Qin, X. Liu, G. Nie*, et al. Peptide Assemblies Integration of Fibroblast Targeting and Cell Penetration Features for Enhanced Antitumor Drugs Delivery. Adv. Mater. 2015, 27, 1865-1873.
9. T. Ji, Y. Zhao, Y. Ding, G. Nie*, Using Nanomaterials to Target and Regulate the Tumor Microenvironment: Diagnostic and Therapeutic Applications. Adv. Mater. 2013, 25, 3508-3525.
10. T. Ji, Y. Zhao, J. Wang, X. Zheng, Y. Tian, G. Nie*, et al. Tumor Fibroblast Specific Activation of Hybrid Ferritin Nanocage-based Optical Probe for Tumor Microenvironment Imaging. Small 2013, 9, 2427-2431.
11. W. Zhang, T. Ji, Y. Li, Y. Zheng, M. Mehta, C. Zhao, A. Liu, D.S. Kohane*. Light-triggered release of conventional localanesthetics from a macromolecular prodrugfor on-demand local anesthesia. Nat. Commun. 2020, doi.org/10.1038/s41467-020-16177-w.
